Lexeo Therapeutics, Inc. is a biotechnology company in the healthcare sector on NASDAQ, led by Tim Van Hauwermeiren, with a market cap of $713.1M. As of Q3 2025, 91% of shares are held by 110 institutional investors, with HENDERSON GROUP PLC as the largest holder at 11.31%.
Overview of institutional ownership in LXEO as of Q3 2025 with a market cap of $358.6M
Based on market cap of $358.6M as of Q3 2025. Institutional (non-HF) excludes hedge funds to avoid double counting.
Institutions with the largest positions in LXEO as of Q3 2025
| Institution | Position Value |
|---|---|
HENDERSON GROUP PLC Institution | $40.5M 0.02% of portfolio |
Frazier Life Sciences Management, L.P. Venture Capital | $29.4M 0.88% of portfolio |
BALYASNY ASSET MANAGEMENT LLC Hedge Fund•Multi-Strategy | $26.0M 0.05% of portfolio |
Affinity Asset Advisors, LLC Hedge Fund•Long/Short | $25.7M 2.61% of portfolio |
CITADEL ADVISORS LLC Hedge Fund•Multi-Strategy | $24.7M 0.02% of portfolio |
Vestal Point Capital, LP Hedge Fund•Long/Short | $21.6M 1.09% of portfolio |
Woodline Partners LP Hedge Fund•Long/Short | $17.1M 0.08% of portfolio |
MILLENNIUM MANAGEMENT LLC Hedge Fund•Multi-Strategy | $15.4M 0.01% of portfolio |
VANGUARD GROUP INC Institution | $14.8M 0.00% of portfolio |
B BlackRock, Inc. Institution | $14.4M 0.00% of portfolio |
Institutional buying and selling activity for LXEO in Q3 2025
| Institution | Net Bought |
|---|---|
HENDERSON GROUP PLC Institution | +$16.1M +2.4M shares |
A ADAR1 Capital Management, LLC Hedge Fund•Long/Short | +$9.2M +1.4M shares |
Point72 Asset Management, L.P. Hedge Fund•Multi-Strategy | +$8.6M +1.3M shares |
6 683 Capital Management, LLC Hedge Fund•Long/Short | +$6.1M +922.7K shares |
DIMENSIONAL FUND ADVISORS LP Long Only Manager | +$5.7M +865.5K shares |
SILVERARC CAPITAL MANAGEMENT, LLC Hedge Fund•Long/Short | +$5.2M +778.6K shares |
B BlackRock, Inc. Institution | +$2.3M +343.1K shares |
Affinity Asset Advisors, LLC Hedge Fund•Long/Short | +$1.9M +281.2K shares |
VANGUARD GROUP INC Institution | +$1.5M +223.4K shares |
AMERIPRISE FINANCIAL INC Institution | +$1.1M +166.5K shares |
| Institution | Net Sold |
|---|---|
Omega Fund Management Inc. Venture Capital | −$4.8M −1.2M shares |
Ally Bridge Group LLC Hedge Fund•Sector | −$3.5M −867.3K shares |
MILLENNIUM MANAGEMENT LLC Hedge Fund•Multi-Strategy | −$3.5M −522.7K shares |
BALYASNY ASSET MANAGEMENT LLC Hedge Fund•Multi-Strategy | −$633.1K −95.3K shares |
UBS Group AG Institution | −$146.0K −22.0K shares |
D DAFNA Capital Management LLC Hedge Fund•Event Driven | −$132.8K −20.0K shares |
SUSQUEHANNA INTERNATIONAL GROUP, LLP Private Equity | −$126.7K −19.1K shares |
Q Quadrature Capital Ltd Institution | −$120.3K −29.8K shares |
B BNP PARIBAS ARBITRAGE, SA Institution | −$117.6K −17.7K shares |
GSA CAPITAL PARTNERS LLP Hedge Fund•Quant | −$58.4K −14.5K shares |
Institutions that initiated new positions or completely exited LXEO in Q3 2025
| Institution | Position Value |
|---|---|
6 683 Capital Management, LLC Hedge Fund•Long/Short | $6.1M 922.7K shares |
SILVERARC CAPITAL MANAGEMENT, LLC Hedge Fund•Long/Short | $5.2M 778.6K shares |
AMERIPRISE FINANCIAL INC Institution | $1.1M 166.5K shares |
V Virtu Financial LLC Institution | $287.3K 43.3K shares |
A AMERICAN CENTURY COMPANIES INC Institution | $240.1K 36.2K shares |
X XTX Topco Ltd Institution | $177.4K 26.7K shares |
H HRT FINANCIAL LLC Institution | $142.8K 21.5K shares |
B Brevan Howard Capital Management LP Institution | $122.2K 18.4K shares |
$118.8K 14.2K shares | |
Scientech Research LLC Hedge Fund•Market Neutral | $89.7K 13.5K shares |
| Institution | Previous Position |
|---|---|
Omega Fund Management Inc. Venture Capital | $4.8M 1.2M shares |
Ally Bridge Group LLC Hedge Fund•Sector | $3.5M 867.3K shares |
Q Quadrature Capital Ltd Institution | $120.3K 29.8K shares |
GSA CAPITAL PARTNERS LLP Hedge Fund•Quant | $58.4K 14.5K shares |
S Skopos Labs, Inc. RIA/Wealth | $15.5K 3.9K shares |
$4.0 1.0 shares |
Institutions with the largest Call and Put options positions in LXEO as of Q3 2025
| Institution | Position Value |
|---|---|
| No call positions found | |
| Institution | Position Value |
|---|---|
SUSQUEHANNA INTERNATIONAL GROUP, LLP Private Equity | $85.7K 129.0 contracts |
Institutions with LXEO as the highest % of their portfolio as of Q3 2025
| Institution | Portfolio Weight |
|---|---|
Affinity Asset Advisors, LLC Hedge Fund•Long/Short | 2.61% $25.7M |
Vestal Point Capital, LP Hedge Fund•Long/Short | 1.09% $21.6M |
A ADAR1 Capital Management, LLC Hedge Fund•Long/Short | 1.02% $10.2M |
Frazier Life Sciences Management, L.P. Venture Capital | 0.88% $29.4M |
Ikarian Capital, LLC Hedge Fund•Event Driven | 0.76% $3.8M |
SILVERARC CAPITAL MANAGEMENT, LLC Hedge Fund•Long/Short | 0.75% $5.2M |
D DAFNA Capital Management LLC Hedge Fund•Event Driven | 0.60% $2.4M |
6 683 Capital Management, LLC Hedge Fund•Long/Short | 0.58% $6.1M |
C CAXTON CORP Institution | 0.50% $115.1K |
P Privium Fund Management B.V. Institution | 0.23% $1.3M |
Discover hedge funds investing in LXEO

| Top Holding | Sector | Market Value | Weight |
|---|---|---|---|
Biotechnology Healthcare | $102.6M | 5.21% | |
Biotechnology Healthcare | $95.1M | 4.83% | |
Medical - Instruments & Supplies Healthcare | $82.0M | 4.16% |
We use cookies for analytics. See our Privacy and Cookie Policy.